ImmunityBio, Inc. (IBRX) currently exhibits a remarkably high short interest, indicating significant bearish sentiment among a substantial portion of the market. According to Fintel data, the reported short interest stands at 76,978,537 shares.1
Key metrics for IBRX's short interest include:
- Short Interest as a Percentage of Float: This figure is 58.54%, which is exceptionally high and suggests that a large proportion of the company's publicly traded shares are held in short positions.1
- Days to Cover: With 13.19 days to cover, it would take over two weeks of average trading volume for short sellers to repurchase all borrowed shares, potentially exacerbating price volatility during a short-covering event.1
- Off-Exchange Short Volume: The off-exchange short volume is 1,378,052 shares, with an off-exchange short volume ratio of 59.27%.1
- Borrow Rate: The current borrow rate for IBRX is 5.46%, and there are approximately 0.40 million shares available to short.2
This elevated short interest level can be a double-edged sword; while it reflects strong negative conviction from some investors, it also sets the stage for a potential short squeeze if positive news or catalysts emerge. Short interest data is typically updated twice monthly, providing a snapshot of market sentiment at those specific points.1
For more detailed information and historical trends, you can explore the dedicated Fintel short interest page for IBRX.
